AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to .5 Billion

AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion

AstraZeneca entered into an unique world license settlement with China’s Dizal Pharmaceutical for the lung most cancers remedy. Source link

Technology

July 14, 2026

LAPD Lets Agreement With Flock Safety Expire Over Privacy Concerns

Flock Security is hitting a tough patch with one among its largest clients. The Los Angeles Police Division let its take care of the surveillance firm expire over the previous weekend, a spokesperson of the division instructed Enterprise Insider on Monday. “We needed to handle among the civil liberty and civil rights concerns and guarantee... Read More

Business

July 14, 2026

California EV Incentive Gives Rivian, Lucid a Price-Cap Edge

California is launching a brand new incentive program for first-time electrical automobile patrons that offers firms like Rivian and Lucid an edge. Gov. Gavin Newsom signed a invoice, SB 168, into regulation on Monday that can give first-time EV prospects an instantaneous incentive of $3,500 on a brand new automobile and $1,750 towards a used... Read More

Finance